Navigation Links
The Electro-Nail - Better Design for Faster Healing. ICAP Ocean Tomo Announces Auction of an Advanced Electro-Nail Implant System for Electro-Magnetic Bone Stimulation in Orthopedics
Date:3/15/2011

CHICAGO, March 15, 2011 /PRNewswire/ -- Developed by Neue Magnetodyn and represented by ICAP Ocean Tomo, this portfolio represents the second lot available from Neue Magnetodyn that will be auctioned at ICAP Ocean Tomo's Spring 2011 Live IP Auction event March 31st in New York City. The assets of this lot disclose an advanced electro-nail implant system used for electro-magnetic bone stimulation.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

Key Characteristics & BenefitsThis patent discloses the following:

  • An advanced electrically conductive interlocking nail system for treating bone fractures.
  • Termed the electro-nail, it is a perfectly standard intramedullary nail system, with an advanced configuration to facilitate quick healing at a fracture site.
  • If needed this nail can be "switched on" to become an active device that accelerates wound healing and combats infection for non-union fractures and open wounds.
  • The system comprises an intramedullary nail with an electrical coil assembly within one of the end caps. The outer contact surface of the nail is electrically conductive and acts as an electrode.
  • Since the electrical coil is placed at one end of the nail system, the introduction of the nail into the broken bone is not obstructed during a surgical operation.
  • If not included in the original procedure, the later addition of the inducible active cap is a relatively simple procedure to complete, compared to the replacement of the total nail, if an active device is called for.
  • The system also provides many biological advantages:
  • 1. Faster consolidation of the fracture.
  • 2. Improved mechanical loading capacity, and reduced risk of implant failure as the bone becomes weight bearing earlier.
  • 3. Minimized risk of infection.
  • 4. Reduced risk of delayed healing or pseudarthrosis.
  • 5. Efficient in therapy resistant pseudarthrosis and infected situations
  • The electro-nail patent on offer was developed from a well established, CE certified earlier model utilized in many successful implantations.
  • Patent coverage is broad and includes issued patents in many major territories including China.

  • Market PotentialThis lot should be of interest to manufacturers of prosthetic devices, orthopedic surgery devices, and biomaterials, and to healthcare service providers.

  • The global orthopedic implants market is forecast to grow to $41.8 billion by 2016, while the US orthopedic implants market is expected to be worth $23 billion in 2012. (1)(2)

  • To learn more about the assets available for sale in this portfolio: Contact Dean Becker of ICAP Ocean Tomo at Dean.Becker@us.icap.comAbout ICAP Ocean Tomo LLCICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.

    About ICAPICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.

    (1) http://www.articlesbase.com/medicine-articles/the-future-of-orthopedic-implants-analysis-and-forecasts-to-2016-2565737.html (2) http://www.reportlinker.com/p091919/US-Orthopedic-Implants-Market.html
    '/>"/>

    SOURCE ICAP Ocean Tomo
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
    2. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
    3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
    4. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
    5. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
    6. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
    7. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
    8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
    9. Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
    10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
    11. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/5/2016)... CENTENNIAL, Colo. , Feb. 5, 2016  As ... about health. The multitude of recommended screenings and tests ... healthy aging a priority. However, for the majority of ... of proactive health planning. For the 37.5 million American ... time like the present to make hearing health a ...
    (Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
    (Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
    Breaking Medicine Technology:
    (Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
    (Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... College President George H. Van Allen have signed a joint enrollment and degree ... a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The ...
    (Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
    (Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
    (Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the day ... feature of patients with eating disorders is significant self-criticism, and consequently these patients experience ... are regarded as maladaptive means for coping with this unease, but also leads to ...
    Breaking Medicine News(10 mins):